Class of Stock [Axis]
Common Stock, par value $0.0001 per share
Warrants, exercisable for one share of common stock
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Members Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Measurement Frequency [Axis]
Fair Value, Recurring [Member]
Investment Type [Axis]
Money Market Fund [Member]
Mutual Fund [Member]
Long-Lived Tangible Asset [Axis]
Equipment [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Furniture and Fixtures [Member]
Computer Equipment [Member]
Leasehold Improvements [Member]
Construction in Progress [Member]
Preferred Units by Name [Axis]
Preferred Units Class F [Member]
Preferred Units Class G [Member]
Legal Entity [Axis]
CTx Board [Member]
Plan Name [Axis]
Equity Incentive Plan (PIU) [Member]
Income Statement Location [Axis]
General and Administrative Expense [Member]
Selling and Marketing Expense [Member]
Exercise Price Range [Axis]
Distribution Threshold $25 Million [Member]
Distribution Threshold $40 Million [Member]
Distribution Threshold $75 Million [Member]
Distribution Threshold $80 Million [Member]
Distribution Threshold $90 Million [Member]
Distribution Threshold $120 Million [Member]
Distribution Threshold $160 Million [Member]
Distribution Threshold [Member]
Business Acquisition [Axis]
Reorganization Merger [Member]
Sale of Stock [Axis]
IPO [Member]
2021 Equity Incentive Plan [Member]
Award Type [Axis]
Equity Option [Member]
Antidilutive Securities [Axis]
Share-Based Payment Arrangement, Option [Member]
Warrant [Member]
Indefinite-Lived Intangible Assets [Axis]
Licensing Agreements [Member]
Phase 3 Clinical Trial [Member]
New Drug Application [Member]
CTx-1301 and CTx-1302 [Member]
CTx-2103 [Member]
CTx-2103 [Member]
Vesting [Axis]
CTx-1301 [Member]
Statement [Table]
Statement [Line Items]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Statement of Financial Position [Abstract]
ASSETS
Current assets:
Cash and cash equivalents
Short-term investments
Miscellaneous receivables
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses
Current installments of obligations under finance leases
Other current liabilities
Total current liabilities
Long-term liabilities:
Obligations under finance leases
Operating lease liabilities
Total liabilities
Stockholders’ Equity
Common Stock, $0.0001 par value; 240,000,000 shares authorized and 11,309,412 shares issued and outstanding as of March 31, 2022 and December 31, 2021
Preferred Stock, $0.0001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding as of December 31, 2021
Additional Paid-in-Capital
Accumulated other comprehensive income
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Income Statement [Abstract]
Operating expenses:
Research and development
General and administrative
Operating loss
Interest and other income (expense), net
Loss before income taxes
Income tax benefit (expense)
Net loss
Other comprehensive income (loss):
Change in unrealized gain on short-term investments
Comprehensive loss
Net loss per share of common stock, basic and diluted
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted
Beginning balance, value
Beginning balance, shares
Member contributions
Net loss
Unrealized losses on available for sale investments
Stock-based compensation expense
Ending balance, value
Ending balance, shares
Statement of Cash Flows [Abstract]
Operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Stock-based compensation
Other
Changes in operating assets and liabilities:
Miscellaneous receivables
Prepaid expenses and other current assets
Operating lease right-of-use assets
Trade accounts payable and accrued expenses
Other current liabilities
Operating lease liabilities
Net cash used in operating activities
Investing activities:
Purchase of property and equipment
Net cash used in investing activities
Financing Activities:
Members’ capital contributions
Proceeds from notes payable
Principal payments on finance lease obligations
Net cash provided by financing activities
Cash and cash equivalents:
Net increase in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Non-cash activities
Property and equipment accrued but not yet paid at end of period
Cash payments:
Interest paid
Accounting Policies [Abstract]
Nature of the Business and Liquidity
Summary of Significant Accounting Policies
Fair Value Disclosures [Abstract]
Fair Value of Assets and Liabilities
Property, Plant and Equipment [Abstract]
Property and Equipment
Payables and Accruals [Abstract]
Accrued Expenses
Equity [Abstract]
Members’ Capital
Retirement Benefits [Abstract]
Profits Interest Plan
Stockholders’ Equity
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation
Income Tax Disclosure [Abstract]
Income Taxes
Earnings Per Share [Abstract]
Net Loss Per Share
Organization, Consolidation and Presentation of Financial Statements [Abstract]
License Agreement
Related Party Transactions [Abstract]
Related Party Transactions
Subsequent Events [Abstract]
Subsequent Events
Basis of Presentation and Principles of Consolidation
Unaudited Interim Financial Information
Concentration of Credit Risk
Miscellaneous Receivables
Impairment of Long-lived Assets
Stock-Based Compensation
Schedule of Assets Measured and Carried at Fair Value on Recurring Basis
Schedule of Property and Equipment
Schedule of Accrued Expenses
Schedule of Various Distribution Thresholds
Summary of Option Activity
Schedule of Fair Value Assumption
Schedule of Effective Income Tax Rate Reconciliation
Schedule of Deferred Tax Assets and Liabilities
Schedule of Net Loss Per Share Basic And Diluted
Schedule of Potentially Dilutive Securities
Federal deposit insurance corporation limit
Impairment of long lived assets
Fair Value, Recurring and Nonrecurring [Table]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost
Gross Unrealized Gain
Gross Unrealized Loss
Fair Value of Current Assets
Fair Value of Non-Current Assets
Fair Value of Total Assets
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Property and equipment, gross
Property and equipment, estimated useful life
Less: accumulated depreciation
Property and equipment, net
Depreciation expense
Professional and consulting fees
Research and development
CIP- Equipment
Other
Accrued Expenses
Schedule of Preferred Units [Table]
Preferred Units [Line Items]
Preferred units, issued
Preferred units, authorized
Issuance of preferred uniits
Share-Based Payment Arrangement, Option, Exercise Price Range [Table]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
2017
2018
2019
2020
2021
Total
Schedule of Defined Benefit Plans Disclosures [Table]
Defined Benefit Plan Disclosure [Line Items]
Vesting period
Stock option, granted
Stock option, issued
Remaining shares issued
Conversion of stock, amount
Conversion of stock into common shares
Noncash compensation expense
Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]
Subsidiary, Sale of Stock [Line Items]
Number of shares of common stock issued
Share issued price per share
Proceeds from public offering
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares Common stock options, outstanding at Beginning Balance
Weighted Average Exercise Price, Outstanding Beginning Balance
Weighted Average Remaining Contractual Life (Years) Outstanding, Ending
Number of Shares, Granted
Weighted Average Exercise Price, Granted
Weighted Average Remaining Contractual Term, Grants
Number of Shares, Exercised
Number of Shares, Forfeitures or expirations
Number of Shares Common stock options, outstanding at Beginning balance
Weighted Average Exercise Price, Outstanding Ending Balance
Aggregate intrinsic value
Shares, Vested and expected to vest
Shares, Exercisable
Risk-free interest rate
Weighted-average expected term (in years)
Expected volatility
Expected dividend yield
Number of shares common stock options
Share based compensation, description
Stock-based compensation expense
Unrecognized compensation cost
Grant-date fair value of options
Share-based compensation arrangements aggregate intrinsic value
Federal income tax benefit at statutory rate
State income tax benefit
Permanent differences
Change in valuation allowance
Other
Total income tax expense
Research and development costs
Unvested stock options
Other
Patents
Net operating losses
Other
Gross deferred income tax assets
Less: valuation allowance
Net deferred income tax asset
Accrual to cash
Property and equipment
Gross deferred income tax liabilities
Net deferred tax asset (liability)
Deferred income tax expense benefit
Deferred tax assets valuation allowance
Weighted average common shares outstanding
Net loss per share, basic and diluted
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total
Milestone payment
Accrued milestone payment
Rental expense
Warrants, exercisable for one share of common stock.
Common Stock, par value $0.0001 per share.
Members Capital [Member]
Members capital contributions.
Unrealized losses on short-term investments.
Property and equipment accrued but not yet paid at end of period.
Unaudited Interim Financial Information [Policy Text Block]
Fair value of current assets.
Fair value of non-current assets.
Money Market Fund [Member]
Accrued, research and development.
Preferred Units Class F [Member]
Preferred Units Class G [Member]
CTx Board [Member]
Equity Incentive Plan (PIU) [Member]
Distribution Threshold $25 Million [Member]
Distribution Threshold $40 Million [Member]
Distribution Threshold $75 Million [Member]
Distribution Threshold $80 Million [Member]
Distribution Threshold $90 Million [Member]
Distribution Threshold $120 Million [Member]
Distribution Threshold $160 Million [Member]
Distribution Threshold [Member]
Incentive distribution distribution per year one.
Incentive distribution distribution per year two.
Incentive distribution distribution per year three.
Incentive distribution distribution per year four.
Incentive distribution distribution per year five.
Reorganization Merger [Member]
2021 Equity Incentive Plan [Member]
Deferred tax liabilities accrual to cash current.
The value of milestone payment.
Phase 3 Clinical Trial [Member]
New Drug Application [Member]
CTx-1301 and CTx-1302 [Member]
CTx-2103 [Member]
CTx-2103 [Member]
Accrued milestone payment.
CTx-1301 [Member]
Deferred tax assets unvested stock options.
Deferred tax assets other current.
Income tax reconciliation permanent difference.
Operating lease right-of-use assets.
Weighted average remaining contractual term, grants.
Unrealized losses on available for sale investments.
CTx-2103 [Member] [Default Label]
Assets, Current
Assets
Liabilities, Current
Liabilities
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Operating Income (Loss)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Shares, Outstanding
Other Noncash Income (Expense)
Increase (Decrease) in Accounts and Notes Receivable
Increase (Decrease) in Prepaid Expense and Other Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
Increase (Decrease) in Other Current Liabilities
Increase (Decrease) in Operating Lease Liability
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities
Finance Lease, Principal Payments
Net Cash Provided by (Used in) Financing Activities
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Stockholders' Equity Note Disclosure [Text Block]
Compensation Related Costs, Policy [Policy Text Block]
Equity Securities, FV-NI, Unrealized Loss
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
AccruedResearchAndDevelopmentCostsCurrent
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
DeferredTaxAssetsOtherCurrent
Deferred Tax Assets, Other
Deferred Tax Assets, Gross
Deferred Tax Assets, Net of Valuation Allowance
DeferredTaxLiabilitiesAccrualToCashCurrent
Deferred Tax Liabilities, Property, Plant and Equipment
Deferred Tax Liabilities, Gross
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount